# Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia

> **NCT01795547** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 295 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole and aripiprazole once-monthly
- **DRUG:** Paliperidone and paliperidone palmitate

## Key facts

- **NCT ID:** NCT01795547
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 295 (ACTUAL)
- **Last updated:** 2017-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01795547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01795547, "Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01795547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*